Publication:
The Value of In Vitro Tests to DiminishDrug Challenges.

dc.contributor.authorMayorga, Cristobalina
dc.contributor.authorDoña, Inmaculada
dc.contributor.authorPerez-Inestrosa, Ezequiel
dc.contributor.authorFernandez, Tahia D
dc.contributor.authorTorres, Maria J
dc.contributor.funderInstitute of Health “Carlos III”
dc.contributor.funderARADyAL
dc.date.accessioned2023-01-25T09:47:08Z
dc.date.available2023-01-25T09:47:08Z
dc.date.issued2017-06-02
dc.description.abstractDrug hypersensitivity reactions have multiple implications for patient safety and health system costs, thus it is important to perform an accurate diagnosis. The diagnostic procedure includes a detailed clinical history, often unreliable; followed by skin tests, sometimes with low sensitivity or unavailable; and drug provocation testing, which is not risk-free for the patient, especially in severe reactions. In vitro tests could help to identify correctly the responsible agent, thus improving the diagnosis of these reactions, helping the physician to find safe alternatives, and reducing the need to perform drug provocation testing. However, it is necessary to confirm the sensitivity, specificity, negative and positive predictive values for these in vitro tests to enable their implementation in clinical practice. In this review, we have analyzed these parameters from different studies that have used in vitro test for evaluating drug hypersensitivity reactions and estimated the added value of these tests to the in vivo diagnosis.
dc.description.sponsorshipWe thank James R. Perkins for his help with the final English language version of this manuscript. The present study has been supported by Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness (grants cofunded by European Regional Development Fund (ERDF): PI12/02529, PI15/01206, RETICs RIRAAF (RD12/0013/0001 and RD12/0013/0003) and ARADyAL (RD16/0006/0001 and RD16/0006/0012); the Ministry of Economy and Competitiveness (grants cofunded by European Regional Development Fund(ERDF): CTQ2016-75870-P) and by Andalusian Regional Ministry of Economy and Knowledge (grants cofunded by European Regional Development Fund (ERDF): CTS-06603); Andalusian Regional Ministry Health (grants: PI-0179-2014, PI-0241-2015 and PI-0250-2016). TD Fernandez holds a “Ramon y Cajal” research contract by Ministry of Economy and Competitiveness (RYC-2013-13138). C Mayorga holds a “Nicolas Monardes” research contract by Andalusian Regional Ministry Health: C-0044-2012 SAS 2013. I Doña holds a “Joan Rodes” research contract (JR15/00036) supported by Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness (grants cofunded by European Social Fund (ESF)).
dc.description.versionSi
dc.identifier.citationMayorga C, Doña I, Perez-Inestrosa E, Fernández TD, Torres MJ. The Value of In Vitro Tests to DiminishDrug Challenges. Int J Mol Sci. 2017 Jun 7;18(6):1222
dc.identifier.doi10.3390/ijms18061222
dc.identifier.essn1422-0067
dc.identifier.pmcPMC5486045
dc.identifier.pmid28590437
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486045/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/1422-0067/18/6/1222/pdf?version=1497003602
dc.identifier.urihttp://hdl.handle.net/10668/11277
dc.issue.number6
dc.journal.titleInternational journal of molecular sciences
dc.journal.titleabbreviationInt J Mol Sci
dc.language.isoen
dc.organizationIBIMA
dc.page.number20
dc.provenanceRealizada la curación de contenido 27/08/2024
dc.publisherMDPI
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.relation.publisherversionhttps://www.mdpi.com/1422-0067/18/6/1222
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectIgE
dc.subjectT-cells
dc.subjectallergy
dc.subjectbasophils
dc.subjectcytokines
dc.subjectdiagnosis
dc.subjectdrug
dc.subjecthypersensitivity
dc.subjectimmunoassays
dc.subjectin vitro
dc.subject.decsHipersensibilidad inmediata
dc.subject.decsHipersensibilidad tardía
dc.subject.decsHipersensibilidad a las drogas
dc.subject.decsInmunoglobulina E
dc.subject.decsLinfocitos T
dc.subject.decsPruebas diagnósticas de rutina
dc.subject.meshDiagnostic Tests, Routine
dc.subject.meshDrug Hypersensitivity
dc.subject.meshHumans
dc.subject.meshHypersensitivity, Delayed
dc.subject.meshHypersensitivity, Immediate
dc.subject.meshImmunoglobulin E
dc.subject.meshT-Lymphocytes
dc.titleThe Value of In Vitro Tests to DiminishDrug Challenges.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number18
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC5486045.pdf
Size:
1.46 MB
Format:
Adobe Portable Document Format